retatrutide release Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide for Weight Loss: TRIUMPH-1

GLP-1 receptor agonists use and incidence of glaucoma: a systematic review and meta-analysis

Phentermine can increase heart rate and blood pressure, while GLP-1 agonists generally show neutral to cardioprotective effects

In concrete numbers, this means that 1 in 8 American adults has been estimated to have tried the drug to date

Individuals who used GLP-1RAs for 0.5, 1, and 1.5 years had IRRs close to 1.0, with no significant decrease in MACE risk at three years, although these estimates varied across specific treatment strategies defined by prior duration and subsequent exposure patterns

Triple vs dual agonist mechanisms, safety data, availability timeline

The early data from obesity trials shows favorable trends in cardiovascular risk factors, but definitive outcome data remains forthcoming